HealthTech
Commercialization of the thrombectomy devices will be highly complementary to CSI’s broader portfolio of advanced technologies used in the treatment of cardiovascular disease.
Hi, what are you looking for?
Flagship Pioneering has partnered with Novo Nordisk to build a portfolio of potential treatments for cardiometabolic and rare diseases.
Boston-based Pear struck a deal with SoftBank, a Japan-based communication and information technology service provider, to develop the digital therapeutic for the treatment of...
Epic Sciences scales its workflow for ctDNA testing with Next Generation Sequencing Leader Fulgent Genetics' expertise in high-volume testing powers Epic's Comprehensive Cancer Profiling
The partnership will enable Altoida to power clinical trials for Click Therapeutics and their pipeline more broadly.
Commercialization of the thrombectomy devices will be highly complementary to CSI’s broader portfolio of advanced technologies used in the treatment of cardiovascular disease.
CereGate is at the forefront of Brain-Computer interfaces that will revolutionize medicine. Learn about their investment prospects and possible strategic partnerships.
MedArrive providers will use Spect’s artificial intelligence-enabled telemedicine platform to screen patients at home for eye diseases such as diabetic retinopathy, glaucoma and age-related...
Find out why Medtronics’ acquisition of Affera may shake up the cardiac ablation devices market.
Comprehensive Profiling on the Epic Platform Maximizes Biomarker Analysis for Discovery and Clinical Studies
ClearSky Medical Diagnostics and Shanghai Accurature Diagnostics have entered into a strategic cooperation agreement related to PD-Monitor, a device using AI technology to assist...